ReviewOrthopaedic journal of sports medicine2026
Return to Sport Following Elbow Dislocation: A Systematic Review.
Review in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Elbow dislocation is the second most common large joint dislocation in athletes, frequently occurring in contact and high-impact sports such as football, wrestling, and gymnastics. While these injuries typically result from a fall onto an outstretched hand with the elbow in near full extension, both nonoperative and surgical treatments have demonstrated high success rates in restoring elbow function, enabling athletes to return to sport (RTS) with favorable functional outcomes. Purpose/Hypothesis: The purpose of this systematic review was to evaluate RTS rate, time to return, and functional outcomes in athletes following elbow dislocation. It was hypothesized that most athletes would successfully return to their sport regardless of treatment modality and that nonoperative treatment would be associated with a shorter recovery timeline compared with surgical intervention. Study Design: Systematic review; Level of evidence, 4. Methods: PubMed, Embase, Cochrane, and Web of Science were searched through March 20, 2025, for studies that investigated the management of elbow dislocation in athletes. Data were extracted on mechanism of injury, dislocation treatment, complications, follow-up duration, and outcome parameters, including RTS, return to the same level of play, time to return, and elbow outcome scores. Results: A total of 9 studies covering 970 athletes met the inclusion criteria for analysis. Across the studies that reported sex and age, 328 of 417 (78.7%) of the athletes were male, with a weighted mean age of 29.6 years. The mean follow-up was 72 months across the 5 studies that provided follow-up data. Across 8 of the 9 studies, 97 of 417 athletes with elbow dislocations (23.3%) underwent surgical treatment, while 320 received nonoperative management. Across 5 studies of 161 dislocations, only 18 cases (11.2%) resulted in complications. Return to any sporting activity, reported for 274 athletes across 7 studies, was observed in 99.3% of patients (n = 272/274) after a mean of 11.4 ± 7.7 weeks. On average, athletes treated nonoperatively returned sooner (8.95 weeks) than surgically treated athletes (16.3 weeks). Mayo Elbow Performance Score, Elbow Self-Assessment Score, and subjective elbow value scores demonstrated excellent elbow performance after injury. Conclusion: The results supported the hypothesis that athletes with elbow dislocation demonstrated excellent functional outcomes and high RTS rates, with most returning within 10 weeks. Most returned regardless of treatment, with nonoperative management generally associated with a shorter return timeline than surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.